Recall | Medicines | 24/05/2017

The marketing authorization holder has informed its supplied customers in a letter dated May 23, 2017, that increased black visible particles have been detected in a batch of "Elotrace - Infusion Additive".Based on these observations, the affected batch 16LC6994 is being recalled.

Name of the medicinal product Elotrace - Infusionszusatz
Marketing authorisation number(s) 1-21430
Marketing authorisation holder Fresenius Kabi Austria GmbH
Batch number(s) 16LC6994
Classification of the recall2
BASG reference number INS-640.001-2 119

Further inquiry note